Skip to main content
Clinical Trials/NCT03896841
NCT03896841
Completed
Not Applicable

Ocular Surface Disease Test Results, Corneal Biomechanical Properties, and Structural Parameters in Patients With Polycystic Ovary Syndrome

Istanbul Medeniyet University0 sites38 target enrollmentMarch 17, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic Ovary Syndrome
Sponsor
Istanbul Medeniyet University
Enrollment
38
Primary Endpoint
Comparison of the corneal biomechanical parameter results (ocular response analyzer).
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Purpose: This study aimed to compare the ocular surface disease test results, anterior segment parameters, and ocular response analyzer (ORA) findings of polycystic ovary syndrome (PCOS) patients with those of healthy reproductive age female controls.

Registry
clinicaltrials.gov
Start Date
March 17, 2013
End Date
March 30, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Istanbul Medeniyet University
Responsible Party
Principal Investigator
Principal Investigator

Mustafa Hepokur

Medical Doctor, Clinical Investigator

Istanbul Medeniyet University

Eligibility Criteria

Inclusion Criteria

  • premenopausal with PCOS

Exclusion Criteria

  • patients with external ocular disease other than dry eye complaints,
  • use of topical drops that can affect the tear film layer,
  • contact lens use histories,
  • those who received hormone therapy for 6 months,
  • those who have systemic medication or systemic disease that may affect the tear film layer and reproductive physiology,
  • previous eye surgeries,
  • smokers and alcohol users,
  • those having diseases (Cushing's syndrome or androgen-secreting tumors) causing similar clinical findings.

Outcomes

Primary Outcomes

Comparison of the corneal biomechanical parameter results (ocular response analyzer).

Time Frame: 1 year

measurement of the corneal hysteresis (CH).

Comparison of the anterior segment parameter results (Pentacam).

Time Frame: 1 year

measurement of the central corneal thickness.

Similar Trials